OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Beneficial Effects of Moderate Hepatic Activin A Expression on Metabolic Pathways, Inflammation, and Atherosclerosis
Huan Liu, Margaret H. Hastings, Robert R. Kitchen, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 43, Iss. 2, pp. 330-349
Open Access | Times Cited: 12
Huan Liu, Margaret H. Hastings, Robert R. Kitchen, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 43, Iss. 2, pp. 330-349
Open Access | Times Cited: 12
Showing 12 citing articles:
SIRT1/SREBPs-mediated regulation of lipid metabolism
Shan Shen, Mingyang Shen, Lirun Kuang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107037-107037
Open Access | Times Cited: 39
Shan Shen, Mingyang Shen, Lirun Kuang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107037-107037
Open Access | Times Cited: 39
Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation
Xiaolei Miao, Arian Alidadipour, Vian Saed, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 11, pp. 1339-1361
Closed Access | Times Cited: 7
Xiaolei Miao, Arian Alidadipour, Vian Saed, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 11, pp. 1339-1361
Closed Access | Times Cited: 7
Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression
Roohi Chaudhary, Ralf Weiskirchen, Marcelo Ehrlich, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Roohi Chaudhary, Ralf Weiskirchen, Marcelo Ehrlich, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction–associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease
Julia Swan, Zoltán Szabó, J. Peters, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116683-116683
Open Access | Times Cited: 2
Julia Swan, Zoltán Szabó, J. Peters, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116683-116683
Open Access | Times Cited: 2
Activin A plays an essential role in migration and proliferation of hepatic stellate cells via Smad3 and calcium signaling
Wei Zhang, Linjing Zhu, Fang Fang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Wei Zhang, Linjing Zhu, Fang Fang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Follistatin lowers blood pressure and improves vascular structure and function in essential and secondary hypertension
Ann Kuganathan, Marcos André Soares Leal, Neel Mehta, et al.
Hypertension Research (2024)
Closed Access | Times Cited: 2
Ann Kuganathan, Marcos André Soares Leal, Neel Mehta, et al.
Hypertension Research (2024)
Closed Access | Times Cited: 2
Circulating Activin A, Kidney Fibrosis, and Adverse Events
Ming‐Tsun Tsai, Shuo‐Ming Ou, Kuo‐Hua Lee, et al.
Clinical Journal of the American Society of Nephrology (2023)
Closed Access | Times Cited: 6
Ming‐Tsun Tsai, Shuo‐Ming Ou, Kuo‐Hua Lee, et al.
Clinical Journal of the American Society of Nephrology (2023)
Closed Access | Times Cited: 6
Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Huan Liu, Armen Yerevanian, Maria Westerhoff, et al.
Diabetes (2023) Vol. 73, Iss. 2, pp. 260-279
Open Access | Times Cited: 5
Huan Liu, Armen Yerevanian, Maria Westerhoff, et al.
Diabetes (2023) Vol. 73, Iss. 2, pp. 260-279
Open Access | Times Cited: 5
Gastrointestinal pharmacology activins in liver health and disease
Matthew Hamang, Benjamin C. Yaden, Guoli Dai
Biochemical Pharmacology (2023) Vol. 214, pp. 115668-115668
Closed Access | Times Cited: 3
Matthew Hamang, Benjamin C. Yaden, Guoli Dai
Biochemical Pharmacology (2023) Vol. 214, pp. 115668-115668
Closed Access | Times Cited: 3
Therapeutic Potential of Polyherbal Tablets: A Comprehensive Assessment of Pharmacological Activity
Suresh Dhakar, Harshal Tare
International Journal of experimental research and review (2023) Vol. 34, Iss. Special Vo, pp. 97-105
Open Access | Times Cited: 3
Suresh Dhakar, Harshal Tare
International Journal of experimental research and review (2023) Vol. 34, Iss. Special Vo, pp. 97-105
Open Access | Times Cited: 3
Activins and Inhibins in Cardiovascular Pathophysiology
Wenyi Tang, Zhilin Gu, Jiuqi Guo, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1462-1462
Open Access
Wenyi Tang, Zhilin Gu, Jiuqi Guo, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1462-1462
Open Access
Hepatic Activin A: An Exciting Target for Cardiometabolic Health
George Notas
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 43, Iss. 2, pp. 350-351
Open Access
George Notas
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 43, Iss. 2, pp. 350-351
Open Access
